GlassScriptPhysician profile
Mathias Masem
NPI 1508810938
$3,947.00
in general payments reported to CMS, 2019-2025
10 companies · $611 in 2025
The $611 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $25.43 · 2021: $111 · 2022: $2,413 · 2023: $108 · 2024: $553 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $2,438.37 | 2020-2022 | |
| Axogen | $603.45 | 2019-2025 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Alafair Biosciences, INC. | $304.84 | 2023-2025 | Versawrap |
| Skeletal Dynamics INC | $151.48 | 2024 | Implate, Align, Geminus |
| Acumed LLC | $127.53 | 2024-2025 | Innate Implant, Inframe Implant |
| Stryker Corporation | $125.35 | 2025 | Variax |
| Endo USA, INC. | $85.61 | 2024-2025 | Xiaflex |
| Electronic Waveform Lab, INC. | $50.12 | 2019-2024 | |
| Integra Lifesciences Corporation | $46.95 | 2019 | |
| Bioventus LLC | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathias Masem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.